FTO and breast cancer: Overexpression of YTHDF2 showed no effects in reducing the mRNA expression level of BNIP3 in FTO-silenced breast cancer cells (Additional file 6: Figure S3A-B), suggesting that FTO mediated-m6A modification decreased BNIP3 expression in the YTHDF2-independent manner.